Go-broke dates pushed back for Social Security, Medicare
WASHINGTON (AP) — A stronger-than-expected economic recovery from the pandemic has...
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (AP) — A stronger-than-expected economic recovery from the pandemic has...
Biden has also endorsed a plan to funnel more money to private insurance companies and escalating plans to privatize the government program for seniors that insures 63 million.
WASHINGTON (AP) — A stronger-than-expected economic recovery from the pandemic has...
WASHINGTON (AP) — Medicare recipients will get a premium reduction — but not until...
Medicare's decision to limit coverage for a controversial new Alzheimer's drug has prompted an outcry among Alzheimer's advocates. The drug is Aduhelm, and despite widespread enthusiasm for it among Alzheimer's patients and advocates, it hasn't been proven to slow the disease. The drug was given accelerated approval by the Food and Drug Administration because it reduces the plaque that develops in the brains of most Alzheimer’s patients.